Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma

Published:2017-07-11 Issue:10 Volume:6 Page:e1346764
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Tsuchiya Nobuhiro¹²,Yoshikawa Toshiaki¹,Fujinami Norihiro¹,Saito Keigo¹,Mizuno Shoichi¹,Sawada Yu¹²,Endo Itaru²,Nakatsura Tetsuya¹

Affiliation:

1. Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwanoha, Kashiwa, Chiba, Japan

2. Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Huku-ura, Kanazawa-ku, Yokohama, Japan

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1346764

Reference44 articles.

1. Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment

2. Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

3. Diagnostic and Treatment Algorithm of the Japanese Society of Hepatology: A Consensus-Based Practice Guideline

4. Management of hepatocellular carcinoma

5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matrikines in the skin: Origin, effects, and therapeutic potential;Pharmacology & Therapeutics;2024-08

2. Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies;Cell Biochemistry and Function;2024-07

3. Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma;Frontiers in Pharmacology;2024-02-01

4. Administration of a glypican‐3 peptide increases the infiltration and cytotoxicity of CD8⁺ T cells against testicular yolk sac tumor, associated with enhancing the intratumoral cGAS/STING signaling;Cancer Medicine;2023-11-20

5. GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill Lung Squamous Cell Carcinoma Cells;Journal of Immunology Research;2023-11-06